SEMA3C and neoplasm: However, two recent studies suggest that SEMA3C may exhibit inhibitory activity on pathologic blood vessel formation (Yang et al, 2015) and in lymphatic endothelial cells and vascular network in tumor progression (Mumblat et al, 2015).